Human Alpha-1-Antitrypsin Kit for use on the SPAPlus analyser, Product #NK034.S. The firm name o...
FDA Device Recall #Z-0002-2018 — Class II — August 23, 2017
Recall Summary
| Recall Number | Z-0002-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 23, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | The Binding Site Group, Ltd. |
| Location | Birmingham, N/A |
| Product Type | Devices |
| Quantity | 361 kits |
Product Description
Human Alpha-1-Antitrypsin Kit for use on the SPAPlus analyser, Product #NK034.S. The firm name on the label is The Binding Site Group Ltd., Birmingham, UK. Product is designed for the quantitative in-vitro determination of Alpha-1-antitrypsin in human serum using the SPAPLUS turbidimetric analyser. The measurement of Alpha-1-antitrypsin aids in the diagnosis of several conditions including adult cirrhosis of the liver. In addition, Alpha-1-antitrypsin deficiency has been associated with pulmonary emphysema. This test should be used in conjunction with other laboratory and clinical findings.
Reason for Recall
The high control for the kit is recovering low and may be out of range for assigned values.
Distribution Pattern
Worldwide Distribution - US Distribution to the state of CA., and to the countries of : United Kingdom, Germany, France, Czech Republic, Belgium, Panama, Bulgaria, Iran, Argentina, Turkey Romania, Colombia, and Saudi Arabia.
Lot / Code Information
Lot #400900, Exp. 12/31/2017, UDI #05051700016421
Other Recalls from The Binding Site Group, Ltd.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0274-2022 | Class II | Freelite Human Lambda Free Kit (for use on the ... | Oct 15, 2021 |
| Z-2030-2021 | Class II | FREELITE Human Kappa Free Kit for use on the Ro... | May 20, 2021 |
| Z-0943-2021 | Class II | Optilite Freelite Mx Kappa Free Kit REF LK016.... | Nov 18, 2020 |
| Z-2071-2020 | Class II | The Optilite Clinical Chemistry Analyzer. IVD. ... | Apr 9, 2020 |
| Z-1500-2020 | Class II | Rheumatoid Factor (RF) Kit for use on SPAPLUS, ... | Nov 6, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.